Compare, Analyse Novartis with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ADCOCK INGRAM (S. Africa) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   ADCOCK INGRAM
EQUITY SHARE DATA
    NOVARTIS
Mar-19
ADCOCK INGRAM
Jun-14
NOVARTIS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs980329-   
Low Rs600237-   
Sales per share (Unadj.) Rs198.797.9-  
Earnings per share (Unadj.) Rs21.0-24.7-  
Cash flow per share (Unadj.) Rs22.3-20.4-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.576.9-  
Shares outstanding (eoy) m24.69168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.9 137.4%   
Avg P/E ratio x37.7-11.5 -328.2%  
P/CF ratio (eoy) x35.5-13.9 -256.2%  
Price / Book Value ratio x2.63.7 69.7%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,50847,815 40.8%   
No. of employees `0000.64.3 13.5%   
Total wages/salary Rs m1,1713,001 39.0%   
Avg. sales/employee Rs Th8,445.43,849.4 219.4%   
Avg. wages/employee Rs Th2,015.7699.0 288.4%   
Avg. net profit/employee Rs Th891.0-970.0 -91.9%   
INCOME DATA
Net Sales Rs m4,90716,526 29.7%  
Other income Rs m783116 676.3%   
Total revenues Rs m5,68916,641 34.2%   
Gross profit Rs m123-2,864 -4.3%  
Depreciation Rs m32713 4.5%   
Interest Rs m16448 3.6%   
Profit before tax Rs m858-3,909 -21.9%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m340244 139.2%   
Profit after tax Rs m518-4,164 -12.4%  
Gross profit margin %2.5-17.3 -14.4%  
Effective tax rate %39.6-6.2 -634.4%   
Net profit margin %10.6-25.2 -41.9%  
BALANCE SHEET DATA
Current assets Rs m8,05512,104 66.5%   
Current liabilities Rs m1,8506,810 27.2%   
Net working cap to sales %126.432.0 394.7%  
Current ratio x4.41.8 244.9%  
Inventory Days Days45111 40.6%  
Debtors Days Days34124 27.4%  
Net fixed assets Rs m1507,055 2.1%   
Share capital Rs m12377 160.8%   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,59212,971 58.5%   
Long term debt Rs m04,558 0.0%   
Total assets Rs m9,82424,503 40.1%  
Interest coverage x54.9-7.7 -710.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.7 74.1%   
Return on assets %5.4-15.2 -35.8%  
Return on equity %6.8-32.1 -21.2%  
Return on capital %11.5-19.8 -58.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,9431,411 -137.7%  
From Investments Rs m2,742-433 -633.2%  
From Financial Activity Rs m-2984,137 -7.2%  
Net Cashflow Rs m5015,114 9.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.54 Rs / ZAR

Compare NOVARTIS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: SANOFI INDIA  DISHMAN PHARMA  ALKEM LABORATORIES  FULFORD INDIA  PIRAMAL ENTERPRISES  



Today's Market

Sensex Ends 127 Points Higher; Auto Stocks Witness Huge Buying(Closing)

Share markets in India continued to trade on a positive note during closing hours today and ended their session marginally higher.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

PSU Stocks Are Looking Positive Now (Fast Profits Daily)

Oct 19, 2020

Has the market changed its opinion on PSUs?

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NOVARTIS SHARE PRICE


Oct 23, 2020 03:36 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

FEATURED VIDEOS

Value Vs Growth Investing: And the Winner Is...

Why ITC and not HUL is my Idea of a Good Investment Right Now

Contrarian Trading in PSU Banks

Why I Asked My Subscribers to Sell Stocks and Move into Cash?

More Featured Videos

MARKET STATS